発血性心不全における多様性イメージング
Jeroen J Bax1, Marcelo Di Carli2, Jagat Narula3
1Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.
Lancet (London, England)
|March 13, 2019
まとめ
現代の非侵襲的イメージングは,心不全の原因を評価し,予後を導き,再血管化や弁修復などの治療法を決定するために重要です. この評価は 薬剤以外にも 最適な治療法を選ぶのに役立ちます
科学分野:
- 心臓病科
- 医療用イメージング
背景:
- 心不全は原因,病理生理学,血液動力学の包括的な評価を必要とします.
- 心臓の構造と機能を評価するために,現代の非侵襲的なイメージング方式は不可欠です.
研究 の 目的:
- 非侵襲的なイメージングを用いて心不全を評価するための体系的なアプローチを概説する.
- 治療の意思決定に 画像がどう影響するかを強調するためです
主な方法:
- 左心室のサイズと機能の段階的な評価
- 冠動脈疾患,ミトラル反吐,肺高血圧,右心房機能の評価
- トリコスピード吐の評価
主要な成果:
- 非侵襲的イメージングは,予後と治療計画のための重要なデータを提供します.
- 画像検査の結果は,再血管化,除細動器の埋め込み,および弁の修復/置換に関する決定を導くことができます.
- 非侵襲的イメージングによる治療をガイドするランダム化制御試験の証拠は限られている.
結論:
- 心不全の患者の管理には,包括的な非侵襲的イメージング戦略が不可欠です.
- イメージングは心不全の 個別化治療戦略において重要な役割を果たします
- 心不全におけるイメージングによる治療の根拠を強化するために,さらなる研究が必要である.
関連する概念動画
Pathophysiology of Heart Failure
3.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction
829
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Heart Failure II: Pathophysiology
855
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
Heart Failure Drugs: Diuretics
935
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935
Heart Failure V: Medical Management
267
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
Heart Failure VI: Adjunct Therapies
313
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
313


